Sign in to view more
Sign in to view more
Taipei Medical University, Taipei, Taiwan, (Medicine), 1972-1979, M.D. Columbia University, New York, U.S.A., (Physiology), 1986-1989, Ph.D. Chief, Division of Cardiology, Taipei Veterans General Hospital, 2004-2009。 Director, Department of Medical Research and Education, Taipei Veterans General Hospital, 2009-。 Associate Professor of Medicine, Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, 1989-1993。 Professor, Department of Microbiology and Immunology, Natl. Yang-Ming Univ., Taipei, Taiwan ,2001-present。 Professor of Medicine, Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, 1993-。 Director, Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, 1998-2004。 Director, Cardiovascular Research Center, National Yang-Ming University, Taipei, 2005-。 Associate Dean, School of Medicine, National Yang-Ming University, Taipei, 2009/08-。 HONORS: Nong Ting Award, 1991, the Republic of China Society of Cardiology Uchida International Award, 1993, Japan Foundation of Cardiovascular Research Allan B. Dove Memorial Medal Award, 2005, the Wire Association International Fellow, American College of Cardiology, 1992- Fellow, European Society of Cardiology, 1990- Dr. Shing-Jong Lin’s major researches are in the fields of 1. molecular pathogenesis of atherosclerosis; 2. the genetic studies of hypertension, dyslipidemia, and coronary artery disease; 3. the role of oxidative stress and inflammation in cardiovascular diseases; 4. the innovation in stent technology; 5. biomarkers and outcome in heart failure studies; 6. vascular medicine and the roles of endothelial progenitor cells in cardiovascular diseases. In vascular medicine studies, our group has demonstrated that high glucose may impair early and late EPCs by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. The MMP-9 is essential for EPCs mobilization and homing in ischemia-induced angiogenesis. The statins, red wine intake, adiponectin, and far infrared may increase the number and function of EPCs.